Literature DB >> 12444349

Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.

Martha Coetzee1, Yifrah Kaminer, Arthuro Morales.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is commonly co-occurring with other psychiatric disorders including substance use disorders. Stimulants have proven to be the pharmacological treatment of choice of ADHD along the life span. Contrary to media hype which compared the addictive potential of methylphenidate (MPD) to cocaine, only a handful of case studies on the abuse of prescription MPD by ADHD patients have been published. This case study centers on the treatment management and aftercare implications of an adult ADHD patient who abused 700 mg of prescribed MPD intranasally during a 3-day binge.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444349     DOI: 10.1080/08897070209511486

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  8 in total

1.  The relationship between past-year drinking behaviors and nonmedical use of prescription drugs: prevalence of co-occurrence in a national sample.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd
Journal:  Drug Alcohol Depend       Date:  2006-04-18       Impact factor: 4.492

2.  Medical use, illicit use and diversion of prescription stimulant medication.

Authors:  Sean Esteban McCabe; Christian J Teter; Carol J Boyd
Journal:  J Psychoactive Drugs       Date:  2006-03

3.  Medical misuse of controlled medications among adolescents.

Authors:  Sean Esteban McCabe; Brady T West; James A Cranford; Paula Ross-Durow; Amy Young; Christian J Teter; Carol J Boyd
Journal:  Arch Pediatr Adolesc Med       Date:  2011-08

4.  Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects.

Authors:  Joshua A Lile; Shanna Babalonis; Cleeve Emurian; Catherine A Martin; Daniel P Wermeling; Thomas H Kelly
Journal:  J Clin Pharmacol       Date:  2010-07-29       Impact factor: 3.126

5.  Developmental rates of immatures of three Chrysomya species (Diptera: Calliphoridae) under the effect of methylphenidate hydrochloride, phenobarbital, and methylphenidate hydrochloride associated with phenobarbital.

Authors:  Fábio Rezende; Marcela A Alonso; Carina M Souza; Patrícia J Thyssen; Arício X Linhares
Journal:  Parasitol Res       Date:  2014-03-15       Impact factor: 2.289

6.  Oral and transdermal DL-methylphenidate-ethanol interactions in C57BL/6J mice: potentiation of locomotor activity with oral delivery.

Authors:  Guinevere H Bell; William C Griffin; Kennerly S Patrick
Journal:  Pharmacol Biochem Behav       Date:  2011-09-08       Impact factor: 3.533

7.  Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine.

Authors:  Bethany R Brookshire; Sara R Jones
Journal:  Synapse       Date:  2012-06-13       Impact factor: 2.562

Review 8.  Misuse of "study drugs:" prevalence, consequences, and implications for policy.

Authors:  Steve Sussman; Mary Ann Pentz; Donna Spruijt-Metz; Toby Miller
Journal:  Subst Abuse Treat Prev Policy       Date:  2006-06-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.